WORLD ANTIVIRAL CONGRESS 2021 SPEAKERS

Dr Brian Abel, Senior Director of Program Development, Aegis Life, Inc.

Dr Nicholas Abuid, Field Application Scientist, ACROBiosystems Inc.

David Anderson, Chief Scientific Officer, VBI Vaccines

Dr James Appleman, SVP R&D and CSO, Primmune Therapeutics, Inc.

Kimberly Armstrong, Chief of the Therapeutics Branch in the Influenza and Emerging Infectious Diseases Division, BARDA

Kabeer Aziz, Co-Founder & Principal, Adjuvant Capital

Dr Andrew Badley, Chair, Mayo Clinic COVID-19 Research Taskforce, Mayo Clinic

Dr Jared Baeten, Vice President, HIV Clinical Development, Gilead Sciences

Carlos Bais, Senior Director, Oncology Biomarker Development, Genenetch Inc

Carlos Bais | Senior Director, Oncology Biomarker Development | Genenetch Inc » speaking at Antiviral Congress 2021

Dr Jessica Baker Flechtner, Chief Scientific Officer, Genocea Biosciences

Lance Baldo, Chief Medical Officer, Adaptive Biotechnologies

Dr Carl Barrett, Vice President Of Translational Sciences, AstraZeneca

Tommy Begres, Sr. Director, Medical Affairs, Emergent BioSolutions

Dr John Beigel, Associate Director, Clinical Research, National Institute of Health - NIAID

Dr John Beigel | Associate Director, Clinical Research | National Institute of Health - NIAID » speaking at Antiviral Congress 2021

Sharon Benzeno, Chief Business Development Officer, Adaptive Biotechnologies

Dr. David Berd, Chief Medical Officer, BioVaxys Technology Corp.

Prof. Pamela Bjorkman, David Baltimore Professor of Biology and Biological Engineering, California Institute of Technology

Mohan Bolisetty, Associate Director, Bristol-Myers Squibb

Jeffrey Borgia, Assoc. Professor, Department of Pathology, Department of Cell & Molecular Medicine, RUSH University Medical Center

Dr David Boulware, Professor Of Medicine, University of Minnesota

Abby Bownas, Principal, AVAC

Dr Sarah Browne, Senior Director, Clinical Development, Altimmune

Rob Burgess, Chief Business Officer, Sino Biological Inc

Dr Dennis Burton, Chair, Department of Immunology and Microbiology, The Scripps Research Institute

David Canton, Senior Director, R&D And Clinical Science, OncoSec Medical

Sumit Chanda, Professor, Department of Immunology and Microbiology, The Scripps Research Institute

Sumit Chanda | Professor, Department of Immunology and Microbiology | The Scripps Research Institute » speaking at Antiviral Congress 2021

Dr Tomas Cihlar, Vice President, Virology, Gilead Sciences, Inc.

Dr Ezra Cohen, Associate Director Of Moores Cancer Center, U.C. San Diego Moores Cancer Center

Keegan Cooke, Principal Scientist, Amgen

James Crowe, Director, Vanderbilt Vaccine Center

James Crowe | Director | Vanderbilt Vaccine Center » speaking at Antiviral Congress 2021

Dr James Crowe, Director, Vanderbilt Vaccine Center

Dr Diane Da Silva, Associate Director, Translational Medicine, Parker Institute for Cancer Immunotherapy

Dr Rea Dabelic, Market Development Manager, 10x Genomics

Heather Darby, Scientific and Applications Marketing Manager, LTG, Luminex Corporation

Dr Mindy Davis, Program Officer - Antiviral Discovery, NIH

Dr Steven Deeks, Professor of Medicine, University of California San Francisco

Dr Steven Deeks | Professor of Medicine | University of California San Francisco » speaking at Antiviral Congress 2021

Manisha Diaz, Associate Director, Research and Development, Eurofins Viracor Biopharma

David Dominguez, Research Associate, Takeda

Amber Donahue, Director, Translational Medicine, Instil Bio

Dr Nathan Duval, Scientist, NTx

David Ede, Technology Consultant - Viral Based Therapeutics, Sartorius Stedim Biotech

Peter Ehrenkranz, Deputy Director, HIV Testing and Treatment, Bill & Melinda Gates Foundation

Vanessa Elharrar, Vice President, Vaccines Business Strategy Lead, ppd

Dr Tom Evans, Chief Scientific Officer, Vaccitech

Dr Tom Evans | Chief Scientific Officer | Vaccitech » speaking at Antiviral Congress 2021

Kimberly Finn, VP, Global Patient Centric Service and PM, Marken

Denise Foster, COVID-19 Vaccine Clinical Director, Chief Nursing Officer, Medical Care Services, County of San Diego Health and Human Services

Dr Felix Frueh, CSO and Co-Founder, Selva Therapeutics, Inc.

Scott Fu, Sales Specialist, InDevR

Dr Hanspeter Gerber, CSO, 3T Biosciences

Brad Gessner, Vice President, Global Medical Lead For Pneumococcal Vaccines, Pfizer

Dr Robert Gish, Managing Director, Hepatitis B. Foundation

Dr Jeffrey Glenn, Professor of Medicine and of Microbiology & Immunology, Stanford University

Dr Anna-Dorothea Gorki, CSO, G.ST Antivirals

John Gregg, CEO, Balinbac Therapeutics, Inc.

Dr Farshad Guirakhoo, Chief Scientific Officer, vaxxinity

Serhat Gumrukcu, Inventor and Co-founder, Enochian BioSciences

Kathryn Hashey, US Vaccine Policy Lead, GSK

Mary Hauser, Senior Scientist, GeoVax, Inc.

Daniel Henderson, CEO, CSO, Verndari

Ted Hibben, CBO, Vaxess

Daniel Hollern, Assistant Professor, Assistant Professor, NOMIS Center for Immunobiology and Microbial Pathogenesis, The Salk Institute

Dr Karl Hostetler, Professor of Medicine, University of California San Diego

Eric Ibsen, CEO, Studylog

Dr Michael Ison, Professor Of Medicine, Northwestern University

Dr Amy Jenkins, Program Manager, D.A.R.P.A.

Karin Jooss, CSO, Gritstone Oncology

Dr Robert Jordan, Senior Program Officer, Bill & Melinda Gates Foundation

Dr Robert Jordan | Senior Program Officer | Bill & Melinda Gates Foundation » speaking at Antiviral Congress 2021

Maria Karasarides, Vice-President, Head Early Assets & Biomarkers, Bristol-Myers Squibb

Dr Scott Kelly, CMO, CytoDyn, Inc.

Kevin Killeen, Chief Scientific Officer, Matrivax R & D Corp

Alexander Kort, SVP Corporate Development, Themis Bioscience

Tom Lake, SVP, Strategic Alliances & Commercialization, Vaxxas

Rekha Lakshmanan, Contributing Expert, Rice University’s Baker Institute for Public Policy; Director, Advocacy And Policy, The Immunization Partnership

Brandon Lamarche, Principal Scientist, Head of xCELLigence Application Development, Agilent

Christopher Larson, Vice President Vector Development, EpicentRx

Christopher Larson | Vice President Vector Development | EpicentRx » speaking at Antiviral Congress 2021

David F. Lasseter, Former Deputy Assistant Secretary of Defense for Countering Weapons of Mass Destruction at DoD; Consultant,, Horizons Global Solutions

Dr Sam Lee, President, Cocrystal Pharma, Inc.

Ofer Levy, Director, Precision Vaccines Program, Boston Children's Hospital Harvard Medical School

Dr Rachel Liberatore, Director of Research & Development, Renbio

Dr Elke Lipka, Ph.D, MBA, CEO, TSRL, Inc

Bruce Lyday, Chief Technology Officer, Primevax Immuno-Oncology, Inc.

Shelly Malhotra, Senior Director, Global Access, IAVI

Shelly Malhotra | Senior Director, Global Access | IAVI » speaking at Antiviral Congress 2021

Alex Mann, Senior Director, Clinical Sciences, hVIVO

Dr Tyler Martin, Chairman, President & CEO, Adjuvance Technologies

Kevin McCowen, Southwest Regional Manager, Wyatt Technology Corporation

Mark McDade, Managing Partner, Qiming Venture Partners

Dr Jonathan Mercado, Biotech Consultant, IsoPlexis

Dr James Merson, Global Therapeutic Area Head, Infectious Diseases, Janssen

Jacqueline Miller, Senior Vice President, Therapeutic Area Head, Infectious Disease, Moderna Therapeutics

Lenny Moise, Director of Vaccine Research, EpiVax Inc

Sandrine Miller Montgomery, President & CEO, Micronoma

Vincent Munster, Chief of Virus Ecology Unit, NIAID, NIH

Mark Newman, CSO, GeoVax, Inc.

Toyin Nwafor, Regional Medical Director, ViiV healthcare

Dr Neal Padte, Chief Operating Officer & Chief Development Officer, Renbio

Dr Wendy Painter, Chief Medical Officer, Ridgeback Biotherapeutics

Dr George Painter, Professor of Pharmacology and Chemical Biology, Emory University

Dr George Painter | Professor of Pharmacology and Chemical Biology | Emory University » speaking at Antiviral Congress 2021

Jason Paragas, President, SaponiQx

Jason Paragas | President | SaponiQx » speaking at Antiviral Congress 2021

Dr Gaston Picchio, Chief Development Officer, Arbutus Biopharma Corporation

Dr Gaston Picchio | Chief Development Officer | Arbutus Biopharma Corporation » speaking at Antiviral Congress 2021

Robert Popovian, Senior Health Policy Fellow, Progressive Policy Institute

Krishna Prasad, Founder, Citranvi Biosciences LLC

kamal puri, CSO, OncoResponse

Dr Barbara Rath, Chair of the ISIRV Epidemiology Group and Board Member with ISIRV and ESGREV and Co-founder & Chair, Vienna Vaccine Safety Initiative

Dr Barbara Rath | Chair of the ISIRV Epidemiology Group and Board Member with ISIRV and ESGREV and Co-founder & Chair | Vienna Vaccine Safety Initiative » speaking at Antiviral Congress 2021

Dr Douglas Richman, Director, Center for Aids Research, University of California San Diego

Paul Robbins, Vice President, Translational Oncology, Instil Bio

Kari Roberts, Business Development Manager, Microbiologics Inc

Paul Schaper, Executive Director of Global Pharmaceutical Public Policy, Merck

Richard Scheuermann, Director, J. Craig Venter Institute

Stephen Schoenberger, Professor, La Jolla Institute for Allergy and Immunology

Dr Kathie Seley-Radtke, Professor Chemistry & Biochemistry, University of Maryland Baltimore County

Dr Kathie Seley-Radtke | Professor Chemistry & Biochemistry | University of Maryland Baltimore County » speaking at Antiviral Congress 2021

Barbara Sennino, Senior Director, Tumor Immunology, PACT Pharma, Inc

Alessandro Sette, Center Head, Division Head, And Professor,, La Jolla Institute for Allergy and Immunology

Dr Robert Shafer, Professor of Medicine-Infectious Diseases, Stanford University School of Medicine (USA)

Dr Robert Shafer | Professor of Medicine-Infectious Diseases | Stanford University School of Medicine (USA) » speaking at Antiviral Congress 2021

Sonia Sharma, Assistant Professor and Director of the Division of Cell Biology, La Jolla Institute

Dr Leah Sibener, Co-Founder, Head of Therapeutic Discovery, 3T Biosciences

Adam Simpson, Co-Founder And Chief Executive Officer, Icosavax, Inc.

William Smith, PI/CEO, Alliance for Multispecialty Research LLC

Trevor Smith, VP of Preclinical Developments, Inovio Pharmaceuticals

Tim Soos, Director Immunology, Codiak Biosciences

Dr Erin Spiegel, VP Clinical & Regulatory Affairs, PharmaJet

Mike Stebbins, Executive Director, Medical CBRN Defense Consortium

Dr Eddie Sullivan, President, Chief Executive Officer And Co-Founder, Sab Biotherapeutics Inc

Dr Eddie Sullivan | President, Chief Executive Officer And Co-Founder | Sab Biotherapeutics Inc » speaking at Antiviral Congress 2021

Dr Todd Suscovich, Chief Technology Officer, Seromyx

Dr Pablo Tamayo, Co-Director, Cancer Center Genomics And Computational Biology Shared Resource, Professor, Division O, University of California, San Diego (UCSD)

Dr Vu Truong, Chief Executive Officer And Chief Scientific Officer, Aridis Pharmaceuticals

Dr Heidi Trusheim, Head of Process Development, IDT Biologika

Dr Sean Tucker, Chief Scientific Officer And Vice President Research, Vaxart

Dr Andrew Vaillant, Chief Scientific Officer, Replicor Inc.

Prof. Wim Van Criekinge, Professor, myNEO NV

Robert Walker, Chief Medical Officer, Meissa Vaccines, Inc

Dr Laura Walker, Chief Scientific Officer, Adagio Therapeutics

James Wassil, COO, Vaxcyte

Dr Ariel Weinberger, CEO, Autonomous

Daniela Weiskopf, Instructor, Division Of Vaccine Discovery, La Jolla Institute for Allergy and Immunology

Dr Michael Wohlfeiler, Chief of Medicine, AIDS Healthcare Foundation

Dr Michael Wohlfeiler | Chief of Medicine | AIDS Healthcare Foundation » speaking at Antiviral Congress 2021

Mahesh Yadav, Principal Scientist, Oncology Biomarker Development, Genentech

Dr Kevin Yeo, Director, Medical Affairs,, Emergent Biosolutions

Arthur Young, President And Founder, InvVax Inc

Dr Benjamin Young, Head Of Global Medical Directors, ViiV healthcare

For sponsorship opportunities

Thomas Hall
thomas.hall@terrapinn.com

For speaking opportunities

Ellie Whitehead
Ellie.Whitehead@terrapinn.com

Co-located with:

World Vaccine & Immunotherapy Congress West Coast